0

    524711

    VISTAPH

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VISTA PHARMACEUTICALS LTD. Share Price Today

    Investment Returns

    Over 1 Month -3.09% Over 3 Months -13.33% Over 6 Months -8.86% Over 1 Year -34.50%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VISTA PHARMACEUTICALS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 40.30
    • P/E Ratio (TTM) -3.52
    • Beta 0.38
    • Book Value / share 5.92
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -5.86
    info icon alternate text

    VISTA PHARMACEUTICALS LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 7.80
    Net Profit -5.86
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.91
    EBITDA -7.02
    Effective Tax Rate (%) 24.58
    Particulars DEC 2025 (Values in Cr)
    Revenue 2.42
    Operating Expense 5.79
    Net Profit -2.32
    Net Profit Margin (%) -95.86
    Earnings Per Share (EPS) -0.41
    EBITDA -2.90
    Effective Tax Rate (%) 29.26
    Particulars SEP 2025 (Values in Cr)
    Revenue 1.46
    Operating Expense 5.27
    Net Profit -2.59
    Net Profit Margin (%) -177.39
    Earnings Per Share (EPS) -0.42
    EBITDA -3.23
    Effective Tax Rate (%) 28.45
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.52
    Operating Expense 3.00
    Net Profit -1.29
    Net Profit Margin (%) -84.86
    Earnings Per Share (EPS) -0.22
    EBITDA -1.11
    Effective Tax Rate (%) 12.83
    Particulars MAR 2025 (Values in Cr)
    Revenue 3.23
    Operating Expense 4.54
    Net Profit -1.50
    Net Profit Margin (%) -46.43
    Earnings Per Share (EPS) -0.79
    EBITDA -0.67
    Effective Tax Rate (%) -40.56
    Particulars MAR 2026 (Values in Cr)
    Revenue 5.40
    Operating Expense 21.86
    Net Profit -12.06
    Net Profit Margin (%) -223.33
    Earnings Per Share (EPS) -1.96
    EBITDA -14.29
    Effective Tax Rate (%) 25.32
    Particulars MAR 2025 (Values in Cr)
    Revenue 10.07
    Operating Expense 15.80
    Net Profit -4.65
    Net Profit Margin (%) -46.17
    Earnings Per Share (EPS) -0.79
    EBITDA -3.59
    Effective Tax Rate (%) 12.09
    Particulars MAR 2024 (Values in Cr)
    Revenue 10.29
    Operating Expense 15.80
    Net Profit -4.51
    Net Profit Margin (%) -43.82
    Earnings Per Share (EPS) -1.03
    EBITDA -3.24
    Effective Tax Rate (%) 12.93
    Particulars MAR 2023 (Values in Cr)
    Revenue 1.00
    Operating Expense 7.28
    Net Profit -5.66
    Net Profit Margin (%) -566.00
    Earnings Per Share (EPS) -1.54
    EBITDA -4.05
    Effective Tax Rate (%) 3.57
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.39
    Operating Expense 3.12
    Net Profit -0.83
    Net Profit Margin (%) -212.82
    Earnings Per Share (EPS) -0.24
    EBITDA -1.04
    Effective Tax Rate (%) 67.57
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.38
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.18
    EBITDA Margin -35.55
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 7.56
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.23
    EBITDA Margin -31.29
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 8.13
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.31
    EBITDA Margin -392.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 9.64
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.34
    EBITDA Margin -282.05
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 8.93
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.42
    EBITDA Margin -120.47
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.73
    Total Assets 60.28
    Total Liabilities 60.28
    Total Equity 45.42
    Share Outstanding 6
    Price to Book Ratio 1.46
    Return on Assets (%) -7.71
    Return on Capital (%) -8.8
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 57.97
    Total Liabilities 57.97
    Total Equity 40.46
    Share Outstanding 4
    Price to Book Ratio 1.41
    Return on Assets (%) -7.78
    Return on Capital (%) -9.32
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.20
    Total Assets 56.02
    Total Liabilities 56.02
    Total Equity 36.70
    Share Outstanding 3
    Price to Book Ratio 1.03
    Return on Assets (%) -10.10
    Return on Capital (%) -12.13
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.07
    Total Assets 55.58
    Total Liabilities 55.58
    Total Equity 35.45
    Share Outstanding 3
    Price to Book Ratio 0.96
    Return on Assets (%) -1.59
    Return on Capital (%) -1.85
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.14
    Total Assets 50.85
    Total Liabilities 50.85
    Total Equity 32.84
    Share Outstanding 3
    Price to Book Ratio 1.01
    Return on Assets (%) -3.94
    Return on Capital (%) -4.61
    Particulars MAR 2025 (Values in Cr)
    Net Income -5.28
    Cash from Operations -6.55
    Cash from Investing -0.44
    Cash from Financing 8.06
    Net change in Cash 0.63
    Free Cash Flow -6.11
    Particulars MAR 2024 (Values in Cr)
    Net Income -5.17
    Cash from Operations -4.91
    Cash from Investing -0.78
    Cash from Financing 5.59
    Net change in Cash -0.10
    Free Cash Flow -4.12
    Particulars MAR 2023 (Values in Cr)
    Net Income -5.87
    Cash from Operations -2.76
    Cash from Investing -1.27
    Cash from Financing 3.11
    Net change in Cash 0.13
    Free Cash Flow -1.49
    Particulars MAR 2022 (Values in Cr)
    Net Income -2.61
    Cash from Operations -0.99
    Cash from Investing -0.01
    Cash from Financing 0.93
    Net change in Cash -0.06
    Free Cash Flow -0.97
    Particulars MAR 2021 (Values in Cr)
    Net Income -3.68
    Cash from Operations -6.74
    Cash from Investing -0.29
    Cash from Financing 6.96
    Net change in Cash -0.08
    Free Cash Flow -6.44
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 18.23 2.12 336.65 23.12 45.50
    BLISS GVS PHARMA LTD 493.60 39.74 4.39 5244.20 118.35 552.90
    CIPLA LTD 1475.00 33.30 3.46 119157.18 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.60 25.80 3.99 1623.41 256.40 564.50
    GLAXOSMITHKLINE PHARMA LT 2579.60 41.51 19.27 43699.98 2088.00 2899.90
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 30.72 5.65 336.65 23.12 45.50
    AMRUTANJAN HEALTH CARE LTD. 519.90 23.30 4.05 1503.06 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8091.35 105.74 23.17 20228.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 493.60 53.42 4.53 5244.20 118.35 552.90

    VISTA PHARMACEUTICALS LTD. shareholding pattern

    Holding
    78.79%
    21.18%
    0.02%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    VISTA PHARMACEUTICALS LTD. Technicals Summary

    6.55 -4.93 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 6.80
    • 26 Days 7.00
    • 10 Days 6.80
    • 50 Days 7.20
    • 12 Days 6.80
    • 100 Days 7.40
    • 20 Days 6.90
    • 200 Days 7.90
    6.72 PIVOT
    First Support 6.48 First Resistance 7.13 Second Support 6.07 Second Resistance 7.37 Third Support 5.83 Third Resistance 7.78
    RSI 46.63 ADX 34.37 MACD -0.17 Williams % R -43.57 Commodity Channel Index (CCI) -76.68
    Date 2026-08-06 Week 7064.00 Same Day 3835.00 Month 9046.00
    1 Year 0.38 3 Year 0.49
    Over 1 Month
    -3.09% down
    Over 1 Year
    -34.50% down
    Over 3 Months
    -13.33% down
    Over 3 Years
    -9.61% down
    Over 6 Months
    -8.86% down
    Over 5 Years
    -8.01% down

    VISTA PHARMACEUTICALS LTD. Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    25 Jun 2015 10.0 2.0 26 Jun 2015

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vista Pharmaceuticals Ltd?

    Answer Field

    Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 6.55 as on Aug 07 2026 03:06 PM.

    What is the Market Cap of Vista Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Vista Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 40.30 as on Aug 07 2026 03:06 PM.

    What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 11.45 and ₹ 5.71.

    What is 1 year return for Vista Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -34.50%.

    What is the P/E Ratio of Vista Pharmaceuticals Ltd Share?

    Answer Field

    As on Aug 07 2026 03:06 PM the price-to-earnings (PE) ratio for Vista Pharmaceuticals Ltd share is -3.52.

    What is the PB ratio of Vista Pharmaceuticals Ltd Share?

    Answer Field

    As on Aug 07 2026 03:06 PM, the price-to-book (PB) ratio for Vista Pharmaceuticals Ltd share is 5.92.

    How to Buy Vista Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vista Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vista Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Vista Pharmaceuticals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |